Published in Clin Gastroenterol Hepatol on February 01, 2005
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
Osteoporosis in inflammatory bowel disease. Am J Med (2009) 1.56
Treatment of inflammatory bowel disease: a review of medical therapy. World J Gastroenterol (2008) 1.52
Endocrine and metabolic manifestations in inflammatory bowel disease. Ann Gastroenterol (2012) 0.93
Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity. Therap Adv Gastroenterol (2013) 0.87
Therapeutic benefits of budesonide in gastroenterology. Ther Adv Chronic Dis (2010) 0.80
Clinical relevance of changes in bone metabolism in inflammatory bowel disease. World J Gastroenterol (2010) 0.78
Manipulating bone disease in inflammatory bowel disease patients. Ann Gastroenterol (2013) 0.76
Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis. Dig Dis Sci (2015) 0.76
Utilization of Preventive Measures for Glucocorticoid-Induced Osteoporosis among Veterans with Inflammatory Bowel Disease. ISRN Gastroenterol (2013) 0.75
Crohn's disease. BMJ Clin Evid (2007) 0.75
Crohn's disease. BMJ Clin Evid (2011) 0.75
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study. BMJ Open Gastroenterol (2016) 0.75
Collagenous enterocolitis and maturity onset type 1 diabetes manifesting as uraemia, malabsorption and extreme weight loss. BMJ Case Rep (2014) 0.75
Limiting fracture risk in Crohn's disease: is there anything better than calcium and vitamin D? Clin Gastroenterol Hepatol (2005) 0.75
MMX(®) technology and its applications in gastrointestinal diseases. Therap Adv Gastroenterol (2017) 0.75
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med (2002) 5.83
Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med (2005) 5.27
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res (2004) 4.04
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. Hepatology (2007) 3.73
Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology (2009) 3.20
Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum (2006) 2.82
A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol (2011) 2.81
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res (2015) 2.74
Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol (2007) 2.68
Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease. Scand J Gastroenterol (2007) 2.50
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology (2004) 2.37
Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet (2011) 2.34
Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. J Clin Densitom (2008) 2.21
Changes in triglyceride levels and risk for coronary heart disease in young men. Ann Intern Med (2007) 2.20
A double-blind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: a patient-tailored approach. Am J Gastroenterol (2006) 2.19
Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology (2002) 2.17
High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol (2005) 2.13
Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet (2002) 2.12
Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J (2013) 2.10
Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study. J Bone Miner Res (2004) 2.01
Survival after hip fracture. Osteoporos Int (2005) 1.93
Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology (2013) 1.88
Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol (2005) 1.84
Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. J Bone Miner Res (2005) 1.81
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res (2009) 1.80
Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology (2006) 1.69
Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care. Hepatology (2011) 1.68
Muscle atrophy and bone loss after 90 days' bed rest and the effects of flywheel resistive exercise and pamidronate: results from the LTBR study. Bone (2005) 1.65
Season of birth, natural light, and myopia. Ophthalmology (2007) 1.65
Risedronate prevents new vertebral fractures in postmenopausal women at high risk. J Clin Endocrinol Metab (2003) 1.65
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum (2008) 1.51
Artificial neural networks are able to recognize gastro-oesophageal reflux disease patients solely on the basis of clinical data. Eur J Gastroenterol Hepatol (2005) 1.51
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50
A prospective, longitudinal study of nonconventional strictureplasty in Crohn's disease. J Am Coll Surg (2004) 1.49
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology (2006) 1.46
Early treatment of stage II sarcoidosis improves 5-year pulmonary function. Chest (2002) 1.46
Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone (2008) 1.44
The use of methotrexate for treatment of inflammatory bowel disease in clinical practice. Dig Liver Dis (2011) 1.43
Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma. J Allergy Clin Immunol (2009) 1.43
Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis. J Hepatol (2006) 1.42
Dual X-ray absorptiometry of hip, heel ultrasound, and densitometry of fingers can discriminate male patients with hip fracture from control subjects: a comparison of four different methods. J Clin Densitom (2002) 1.40
Managing complex patients on a medical psychiatric unit: an observational study of university hospital costs associated with medical service use, length of stay, and psychiatric intervention. J Psychosom Res (2009) 1.40
Acid-suppressive therapy with esomeprazole for relief of unexplained chest pain in primary care: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol (2012) 1.40
Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD. J Bone Miner Res (2005) 1.39
Acute changes in neuromuscular excitability after exhaustive whole body vibration exercise as compared to exhaustion by squatting exercise. Clin Physiol Funct Imaging (2003) 1.39
Biologic therapy for inflammatory bowel disease. Drugs (2005) 1.38
The prevalence of reversible cardiovascular risk factors in Israelis aged 25-55 years. Isr Med Assoc J (2006) 1.38
Vascular adaptation to deconditioning and the effect of an exercise countermeasure: results of the Berlin Bed Rest study. J Appl Physiol (1985) (2005) 1.36
Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care (2008) 1.34
Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol (2011) 1.33
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. Mol Cancer (2008) 1.31
Is muscle power output a key factor in the age-related decline in physical performance? A comparison of muscle cross section, chair-rising test and jumping power. Clin Physiol Funct Imaging (2004) 1.28
Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin (2004) 1.28
Increase in vertebral fracture risk in postmenopausal women using omeprazole. Calcif Tissue Int (2008) 1.26
Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest. J Bone Miner Res (2004) 1.26
Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago. World J Surg (2002) 1.26
Saprotrophic and mycoparasitic components of aggressiveness of Trichoderma harzianum groups toward the commercial mushroom Agaricus bisporus. Appl Environ Microbiol (2003) 1.25
Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. J Clin Gastroenterol (2005) 1.24
When should the doctor order a spine X-ray? Identifying vertebral fractures for osteoporosis care: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2004) 1.24
Treatment of chronic lower back pain with lumbar extension and whole-body vibration exercise: a randomized controlled trial. Spine (Phila Pa 1976) (2002) 1.23
Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas. Cancer Prev Res (Phila) (2011) 1.23
Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn's disease: a prospective comparative study. Am J Gastroenterol (2003) 1.23
Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice. Clin Interv Aging (2008) 1.22
Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center. J Clin Gastroenterol (2003) 1.21
Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab (2010) 1.21
Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol (2004) 1.20
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. J Rheumatol (2008) 1.18
Association of self-reported alcohol use and hospitalization for an alcohol-related cause in Scotland: a record-linkage study of 23,183 individuals. Addiction (2009) 1.18
Short CDAI: development and validation of a shortened and simplified Crohn's disease activity index. Inflamm Bowel Dis (2011) 1.18
Impact of bed rest on conduit artery remodeling: effect of exercise countermeasures. Hypertension (2010) 1.17
Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol (2007) 1.17
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies. Autoimmun Rev (2010) 1.15
Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia. Scand J Gastroenterol (2007) 1.14
Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis (2005) 1.13
Interpolity exchange of basalt tools facilitated via elite control in Hawaiian archaic states. Proc Natl Acad Sci U S A (2011) 1.13
Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study. Scand J Gastroenterol Suppl (2006) 1.12
Reproducibility of the jumping mechanography as a test of mechanical power output in physically competent adult and elderly subjects. J Am Geriatr Soc (2004) 1.11
Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology (2013) 1.11
Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis. Rheumatol Int (2010) 1.09
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response. Inflamm Bowel Dis (2012) 1.08
The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am J Gastroenterol (2007) 1.08
Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins. J Med Virol (2003) 1.08
Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis (2006) 1.07
Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study. Bone (2013) 1.05
A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. Stat Methods Med Res (2008) 1.03
Long term bed rest with and without vibration exercise countermeasures: effects on human muscle protein dysregulation. Proteomics (2010) 1.02
Outcome of non-variceal acute upper gastrointestinal bleeding in relation to the time of endoscopy and the experience of the endoscopist: a two-year survey. World J Gastroenterol (2005) 1.02
Intermittent small-bowel obstruction caused by gastric adenocarcinoma in a Meckel's diverticulum. Gastrointest Endosc (2005) 1.01
The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis (2004) 1.01
Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease course. Scand J Gastroenterol (2007) 1.00
Ryanodine receptor type-1 (RyR1) expression and protein S-nitrosylation pattern in human soleus myofibres following bed rest and exercise countermeasure. Histochem Cell Biol (2008) 1.00
WISE-2005: bed-rest induced changes in bone mineral density in women during 60 days simulated microgravity. Bone (2011) 1.00
Dyspeptic symptoms in primary care. An observational study in general practice. Eur J Gastroenterol Hepatol (2002) 0.99